Trial intelligence / Profile preview

Sildenafil on Exercise Function in Fontan Circulation

NCT00964782Phase 4Completed

Sponsor
Penn State Health Milton S. Hershey Medical Center
Start
Aug 2009
Primary completion
May 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ASP-001 in Fontan circulation (2 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoints: Change in Exercise Capacity Measured Via Maximum Oxygen Consumed During Exercise at 1 hour and Change in Exercise Capacity Measured Via Exercise Time at 1 hour. Started Aug 2009; status: completed.

02

Drugs

ASP-001
03

Conditions

Fontan circulation

Beyond the preview

Go deeper on NCT00964782.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00964782.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call